CB Oncology Partners (Tables)

3 Months Ended

Mar. 31, 2021

CB Oncology Partners LLC [Member]

Schedule of Equity Method Investments [Line Items]

Equity Method Investment Summarized Financial Information

The following table presents the summarized financial information of CBOP:

CBOP Condensed Income Statement Information

	Three Months Ended March 31,
	2021		2020
Patient revenue	$	471,000	$	467,000
Net income (loss)	$	62,000	$	(216,000	)
USNC's equity in income (loss) of CBOP	$	18,000	$	(52,000	)

CBOP Condensed Balance Sheet Information

	December 31,
		2021			2020
Current assets	$	446,000		$	385,000
Noncurrent assets		4,121,000			4,271,000
Total assets	$	4,567,000		$	4,656,000
Current liabilities	$	3,154,000		$	3,181,000
Noncurrent liabilities		3,547,000			3,684,000
Deficit		(2,134,000	)		(2,209,000	)
Total liabilities and deficit	$	4,567,000		$	4,656,000